Delivery Order SPE2DB20D2104-SPE2DB24FT49R
Award Date 4/8/24
Potential Completion Date 4/9/24
Potential Value $3.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $13,953.86, has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $13,933.44 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has an ultimate completion date of April 1, 2024. AmerisourceBergen Drug Corp previously received an indefinite delivery contract from DLA Troop Support Medical with a potential value of $999,999,999.00 and a performance...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a potential value of $2,902.80 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. The company also holds an indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRULICITY 0.75 mg/0.5 ml pens. The $7,965.65 contract has an ultimate completion date of April 2, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML prescription medication. The order, valued at $1,886.82, has a completion date of March 1, 2024. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order and has no set-aside designation. Additionally, AmerisourceBergen Drug Corp holds an...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceuticals. The contract has a potential value of $2,760.96 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML medication. The $2,031.96 contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor and this order is a component of a larger indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00 through December...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $3,533.04 contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, with a performance period through March 4, 2024. This order is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract with DLA, valued up to $999,999,999.00, to provide a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a ceiling value of $2,177.10 and a period of performance through March 21, 2024. This delivery order is issued under Amerisourcebergen's existing indefinite delivery contract with DLA, valued up to $999,999,999.00 through December 31, 2025,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The delivery order, valued at $2,902.80, has an ultimate completion date of April 1, 2024. AmerisourceBergen Drug Corp is the prime contractor and serves as the primary vendor for pharmaceutical and medical supply deliveries to DLA Troop Support Medical...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT49RDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The delivery order, valued at $3,542.40, has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract does not have any set-aside designation.
Generated 7/8/24, 9:30 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 4/8/24 |